Stay updated on NeoPATH Clinical Trial
Sign up to get notified when there's something new on the NeoPATH Clinical Trial page.

Latest updates to the NeoPATH Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe Neoadjuvant Nab-paclitaxel trial record is displayed, including its eligibility criteria, treatment plan, outcome measures, and contact information. The NIH transition banner and 403 error message are no longer shown.SummaryDifference51%

- Check16 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.8.0 instead of v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.1 to v3.7.2 on the study page’s 403 Forbidden error screen.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision: v3.7.0 is now shown on the page, indicating a version update. A substantial set of MeSH terms and related topic listings was removed from the page, reducing the amount of indexing terms displayed.SummaryDifference18%

Stay in the know with updates to NeoPATH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NeoPATH Clinical Trial page.